Title 42 — The Public Health and Welfare
Part B · Chapter 6A — Public Health Service
§ 284r. Basic research
Statutory text
Developing policies
Not later than 2 years after , the Director of the National Institutes of Health (referred to in this section as the “Director of the National Institutes of Health”), taking into consideration the recommendations developed under section 2039,1 shall develop policies for projects of basic research funded by National Institutes of Health to assess—
relevant biological variables including sex, as appropriate; and
how differences between male and female cells, tissues, or animals may be examined and analyzed.
Revising policies
The Director of the National Institutes of Health may update or revise the policies developed under paragraph (1) as appropriate.
Consultation and outreach
In developing, updating, or revising the policies under this section, the Director of the National Institutes of Health shall—
consult with—
the Office of Research on Women’s Health;
the Office of Laboratory Animal Welfare; and
appropriate members of the scientific and academic communities; and
conduct outreach to solicit feedback from members of the scientific and academic communities on the influence of sex as a variable in basic research, including feedback on when it is appropriate for projects of basic research involving cells, tissues, or animals to include both male and female cells, tissues, or animals.
Additional requirements
The Director of the National Institutes of Health shall—
ensure that projects of basic research funded by the National Institutes of Health are conducted in accordance with the policies developed, updated, or revised under this section, as applicable; and
encourage that the results of such research, when published or reported, be disaggregated as appropriate with respect to the analysis of any sex differences.
Footnotes
- 1 See References in Text note below.
Legislative history
Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.
21st Century Cures Act
Pub. L. 114–255 div. A title II § 2038(g) · 130 Stat. 1033
Enacted · 42 U.S.C. § 284r
(Pub. L. 114–255, div. A, title II, § 2038(g), Dec. 13, 2016, 130 Stat. 1066.)
Source evidence
Code source credit
(Pub. L. 114–255, div. A, title II, § 2038(g), Dec. 13, 2016, 130 Stat. 1066.)Enacted provision · exact public law section
(g) Basic Research.— (1) Developing policies.— Not later than 2 years after the date of enactment of this Act, the Director of the National Institutes of Health (referred to in this section as the “Director of the National Institutes of Health”), taking into consideration the recommendations developed under section 2039, shall develop policies for projects of basic research funded by National Institutes of Health to assess— (A) relevant biological variables including sex, as appropriate; and (B) how differences between male and female cells, tissues, or animals may be examined and analyzed. (2) Revising policies.— The Director of the National Institutes of Health may update or revise the policies developed under paragraph (1) as appropriate. (3) Consultation and outreach.— In developing, updating, or revising the policies under this section, the Director of the National Institutes of Health shall— (A) consult with— (i) the Office of Research on Women’s Health; (ii) the Office of Laboratory Animal Welfare; and (iii) appropriate members of the scientific and academic communities; and (B) conduct outreach to solicit feedback from members of the scientific and academic communities on the influence of sex as a variable in basic research, including feedback on when it is appropriate for projects of basic research involving cells, tissues, or animals to include both male and female cells, tissues, or animals. (4) Additional requirements.— The Director of the National Institutes of Health shall— (A) ensure that projects of basic research funded by the National Institutes of Health are conducted in accordance with the policies developed, updated, or revised under this section, as applicable; and (B) encourage that the results of such research, when published or reported, be disaggregated as appropriate with respect to the analysis of any sex differences.
1 of 1 references resolved to an enrolled provision
Editorial Notes
References in Text
Section 2039, referred to in par. (1), is section 2039 of Pub. L. 114–255, which is set out as a note under section 282 of this title.
Codification
Section was enacted as part of the 21st Century Cures Act, and not as part of the Public Health Service Act which comprises this chapter.